PubRank

F Pasquier

Author PubWeight™ 133.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005 21.67
2 Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013 9.46
3 A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001 5.81
4 The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 1999 3.49
5 Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology 2007 2.61
6 APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry 2011 2.31
7 Comparison of 7.0-T T₂*-magnetic resonance imaging of cerebral bleeds in post-mortem brain sections of Alzheimer patients with their neuropathological correlates. Cerebrovasc Dis 2011 2.05
8 Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2005 1.81
9 Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry 2008 1.71
10 Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry 2011 1.59
11 Prediction of pathology in primary progressive language and speech disorders. Neurology 2009 1.57
12 Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry 2008 1.56
13 Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry 2009 1.51
14 Decreased morbidity from acute bacterial spinal epidural abscesses using computed tomography and nonsurgical treatment in selected patients. Ann Neurol 1985 1.43
15 Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 2001 1.40
16 Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging. Eur Neurol 1997 1.36
17 Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am J Hum Genet 1997 1.27
18 White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol 1998 1.25
19 Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease. Neurology 2002 1.22
20 Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry 2012 1.20
21 Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet 1998 1.20
22 EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol 2012 1.19
23 The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum Mol Genet 2000 1.16
24 A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum Mol Genet 1998 1.14
25 Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology 2002 1.14
26 Sleep disorders in aging and dementia. J Nutr Health Aging 2010 1.10
27 Confusional state in stroke: relation to preexisting dementia, patient characteristics, and outcome. Stroke 1999 1.07
28 Resistance to Bacillus sphaericus involves different mechanisms in Culex pipiens (Diptera:Culicidae) larvae. J Med Entomol 1997 1.06
29 Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. Stroke 1997 1.03
30 The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study. Eur J Neurol 2011 1.03
31 Perception of emotion in frontotemporal dementia and Alzheimer disease. Alzheimer Dis Assoc Disord 1999 1.01
32 Medial temporal lobe atrophy in stroke patients: relation to pre-existing dementia. J Neurol Neurosurg Psychiatry 1998 0.99
33 SPECT data in a case of secondary Capgras delusion. Psychopathology 1994 0.97
34 Methylenetetrahydrofolate reductase deficiency revealed by a neuropathy in a psychotic adult. J Neurol Neurosurg Psychiatry 1994 0.97
35 Depressive symptoms after stroke and relationship with dementia: A three-year follow-up study. Neurology 2004 0.96
36 CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model. Cell Death Dis 2012 0.94
37 Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc HmPAO SPECT data. J Neurol Neurosurg Psychiatry 2000 0.94
38 Frontotemporal behavioral scale. Alzheimer Dis Assoc Disord 1998 0.93
39 White matter changes and poststroke dementia. Dement Geriatr Cogn Disord 1998 0.93
40 Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. J Neuropathol Exp Neurol 2006 0.92
41 Epidemiology of vascular dementia. Haemostasis 1999 0.92
42 Leukoaraiosis more than dementia is a predictor of stroke recurrence. Stroke 2003 0.92
43 Cognitive decline and survival in Alzheimer's disease according to education level. Dement Geriatr Cogn Disord 2007 0.90
44 [Neuropsychological evaluation before and after thalamic stimulation in 9 patients with Parkinson disease]. Rev Neurol (Paris) 1992 0.90
45 Influence of cognitive impairment on the institutionalisation rate 3 years after a stroke. J Neurol Neurosurg Psychiatry 2006 0.90
46 The nature of semantic memory deficits in Alzheimer's disease: new insights from hyperpriming effects. Brain 2001 0.89
47 Association between coding variability in the LRP gene and the risk of late-onset Alzheimer's disease. Hum Genet 1999 0.89
48 Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease. J Med Genet 2003 0.89
49 Perception of emotion on faces in frontotemporal dementia and Alzheimer's disease: a longitudinal study. Dement Geriatr Cogn Disord 2004 0.89
50 Poststroke dementia. Cerebrovasc Dis 2006 0.88
51 Vascular dementia: the role of cerebral infarcts. Alzheimer Dis Assoc Disord 2000 0.88
52 The cognitive syndrome of vascular dementia: implications for clinical trials. Alzheimer Dis Assoc Disord 2000 0.88
53 Explicit memory in frontotemporal dementia: the role of medial temporal atrophy. Dement Geriatr Cogn Disord 1998 0.87
54 [Chiasmatic tuberculoma. 2 cases]. Sem Hop 1984 0.87
55 Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease. Neurosci Lett 1997 0.86
56 Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases: a semi-quantitative 7.0 T magnetic resonance imaging study. Eur J Neurol 2014 0.85
57 Progression of Alzheimer disease in Europe: data from the European ICTUS study. Curr Alzheimer Res 2012 0.85
58 Detection of microbleeds in post-mortem brains of patients with frontotemporal lobar degeneration: a 7.0-Tesla magnetic resonance imaging study with neuropathological correlates. Eur J Neurol 2012 0.85
59 Acute polyradiculoneuropathy after amitriptyline overdose. Br Med J (Clin Res Ed) 1987 0.84
60 Generation effect in short-term verbal and visuospatial memory: comparisons between dementia of Alzheimer type and dementia of frontal lobe type. Cortex 1996 0.83
61 [The profile of memory disturbance in early Lewy body dementia differs from that in Alzheimer's disease]. Rev Neurol (Paris) 2003 0.83
62 Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease. Mol Psychiatry 2007 0.83
63 A FE65 polymorphism associated with risk of developing sporadic late-onset alzheimer's disease but not with Abeta loading in brains. Neurosci Lett 2000 0.83
64 [Dysfunction of the magnocellular pathway in Alzheimer's disease]. Rev Neurol (Paris) 2002 0.82
65 Superficial siderosis of the central nervous system: a post-mortem 7.0-tesla magnetic resonance imaging study with neuropathological correlates. Cerebrovasc Dis 2013 0.82
66 Influence of pre-existing dementia on the risk of post-stroke epileptic seizures. J Neurol Neurosurg Psychiatry 2005 0.81
67 [VZV-related myelitis: a pathophysiological hypothesis]. Rev Neurol (Paris) 2007 0.81
68 Creutzfeldt-Jakob disease: neurophysiologic visual impairments. Neurology 1998 0.81
69 [Dementia following bipolar disorder]. Encephale 2008 0.81
70 Cerebrovascular lesions in patients with frontotemporal lobar degeneration: a neuropathological study. Neurodegener Dis 2012 0.81
71 Severe hypoglycorrhachia after subarachnoid hemorrhage. Two cases with spontaneous recovery in adults. Acta Neurol Belg 1987 0.80
72 Calculation and number processing in mild Alzheimer's disease. J Clin Exp Neuropsychol 1995 0.80
73 Disturbance of sensory filtering in dementia with Lewy bodies: comparison with Parkinson's disease dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2005 0.80
74 Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease. J Nucl Med 1999 0.80
75 [Benign choroid plexus papilloma. 2 local recurrences and intraventricular seeding]. Neurochirurgie 1986 0.80
76 Melanotic meningioma. Report of a case and review of the literature. Neurochirurgia (Stuttg) 1985 0.79
77 Determination of medial temporal lobe atrophy in early Alzheimer's disease with computed tomography. Lancet 1994 0.78
78 Long-term outcome of acute and subacute myelopathies. J Neurol 2009 0.78
79 [A possible complication of sickle-cell disease: pulmonary aspergillosis]. Rev Med Interne 2005 0.78
80 Silent infarcts in stroke patients: patient characteristics and effect on 2-year outcome. J Neurol 2001 0.78
81 [Primitive leptomeningeal malignant melanoma: a rare etiology of pachymeningitis and leptomeningitis]. Rev Neurol (Paris) 2010 0.77
82 Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology. J Clin Pharm Ther 2011 0.77
83 [Memory clinics: long-term follow-up]. Therapie 1998 0.77
84 Prevention of dementia: Syst-Eur trial. Lancet 1999 0.77
85 Convulsive effects of tacrine. Lancet 1996 0.77
86 Dementia in stroke. Neurology 1996 0.77
87 How can cerebral infarcts and hemorrhages lead to dementia? J Neural Transm Suppl 2000 0.77
88 [Cognitive disorders and adult grade II and III gliomas: analysis of a series of 15 patients]. Neurochirurgie 2008 0.76
89 Neuropsychiatric afflictions of modern French presidents: Marechal Henri-Philippe Petain and Paul Deschanel. Eur J Neurol 1999 0.76
90 No effect of the alpha1-antichymotrypsin A allele in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1997 0.76
91 [Clinical and biochemical study of 37 cases of endocrine sterility, with corpus luteum estrogenic deficiency in Jayle's dynamic test, treated by HMG-O in the preovulation phase]. Gynecol Obstet (Paris) 1971 0.76
92 An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels. Exp Neurol 2009 0.76
93 [Behavior assessment in Alzheimer type dementia using the disruptive behavior questionnaire]. Presse Med 1996 0.76
94 Is there a typical pattern of brain SPECT imaging in Alzheimer's disease? Dement Geriatr Cogn Disord 2001 0.76
95 Therapeutic management in ambulatory elderly patients with atrial fibrillation: the S.AGES cohort. J Nutr Health Aging 2015 0.76
96 Analysing Time to Event Data in Dementia Prevention Trials: The Example of the GuidAge Study of EGb761®. J Nutr Health Aging 2015 0.76
97 [Wernicke-Korsakoff syndrome: diagnostic contribution of magnetic resonance imaging] Rev Neurol (Paris) 2002 0.76
98 Gesture comprehension, knowledge and production in Alzheimer's disease. Eur J Neurol 2012 0.76
99 Mild Alzheimer's disease: a "position paper". J Nutr Health Aging 2009 0.76
100 Behavioral effects of trazodone in Alzheimer's disease. J Clin Psychiatry 1994 0.75
101 [Specialized consultation of memory disorders or multidisciplinary consultation?]. Presse Med 1994 0.75
102 Prestroke dementia in patients with atrial fibrillation. Frequency and associated factors. J Neurol 2005 0.75
103 Alterations of the blood-brain barrier and glial cells in white matter lesions in cerebrovascular and Alzheimer's disease patients. Stroke 1997 0.75
104 Tacrine efficacy in Lewy body dementia. Int J Geriatr Psychiatry 1998 0.75
105 Tolerance to tacrine, arterial hypotension and leuko-araiosis in Alzheimer's disease. Age Ageing 1998 0.75
106 Association between medial temporal lobe atrophy on CT and parietotemporal uptake decrease on SPECT in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1997 0.75
107 [Wernicke-Korsakoff syndrome: diagnostic contribution of magnetic resonance imaging]. Rev Neurol (Paris) 2002 0.75
108 [Arterial hypertension and cognitive decline]. Rev Neurol (Paris) 1999 0.75
109 [Mitochondrial anomalies in oculopharyngeal muscular dystrophy]. Rev Neurol (Paris) 1997 0.75
110 [Magnetic resonance imaging in vascular dementia]. J Mal Vasc 1995 0.75
111 [Dorsal interapophyseal arthropathy and spinal cord compression in syringomyelia]. Neurochirurgie 1984 0.75
112 Different patterns of Mini Mental Status Examination responses in primary progressive aphasia and Alzheimer's disease. Eur J Neurol 2006 0.75
113 [Cadasil: a new familial disease responsible for cerebral infarction and dementia]. Rev Med Interne 1995 0.75
114 [Lewy body dementia]. Rev Neurol (Paris) 1998 0.75
115 [Acute rhombencephalitis with fever and bilateral hearing loss secondary to Gougerot-Sjögren's syndrome]. Rev Neurol (Paris) 2002 0.75
116 [Mental akinesia and memory disorders following carbon monoxide poisoning]. Acta Neurol Belg 1991 0.75
117 [Treatment of psychiatric and behavioural symptoms in Alzheimer's disease]. Rev Neurol (Paris) 2003 0.75
118 Euphoria with buspirone after fluoxetine treatment. Am J Psychiatry 1993 0.75
119 [Behavioral problems in Alzheimer disease: current and future treatments]. Rev Neurol (Paris) 2009 0.75
120 [Close genetic relation between determinants coding for the HLA-D region, detected by the technique of mixed primary and secondary lymphocyte culture and by serology of B lymphocytes]. C R Acad Sci Hebd Seances Acad Sci D 1977 0.75
121 [Alzheimer's disease: a public health problem: yes, but a priority?]. Rev Neurol (Paris) 2002 0.75
122 [Memory consultation without medical prescription]. Presse Med 1996 0.75
123 [Comments on the practice guideline for the diagnosis of Alzheimer's disease]. Presse Med 2001 0.75
124 Sundowning syndrome in demented patients without neuroleptic therapy. Arch Gerontol Geriatr 2004 0.75
125 [Ophthalmologic manifestations and panhypopituitarism in a pituitary metastasis disclosing bronchial cancer]. Rev Otoneuroophtalmol 1985 0.75
126 [Biological markers in Alzheimer disease: what are the chances for less slow diagnosis?]. Rev Neurol (Paris) 2009 0.75
127 [63 cases of sterility with corpus luteum estrogen deficiency treated with clomiphene citrate]. Bull Fed Soc Gynecol Obstet Lang Fr 1971 0.75
128 [Role of Alzheimer's type dementia among dementias of the elderly]. Bull Acad Natl Med 1996 0.75
129 [Professional guidelines for the diagnosis and management of Alzheimer's disease and related diseases, HAS (Haute Autorité de Santé) 2008]. Rev Neurol (Paris) 2008 0.75
130 The topography of cortical microbleeds in frontotemporal lobar degeneration: a post-mortem 7.0-tesla magnetic resonance study. Folia Neuropathol 2016 0.75
131 Possible revelation of latent myasthenia gravis by labetalol chlorhydrate. Acta Clin Belg 1987 0.75
132 [Regressive oculomotor disorders in meningioma of the cavernous sinus]. Rev Otoneuroophtalmol 1985 0.75
133 [Semantic dementia: reflexions of a French working group for diagnostic criteria and constitution of a patient cohort]. Rev Neurol (Paris) 2008 0.75
134 Meningitis caused by Salmonella enteritidis in an adult. Acta Clin Belg 1992 0.75
135 [Fulminating cryptococcal meningoencephalitis. An anatomo-clinical case]. Rev Neurol (Paris) 1990 0.75
136 [Adrenoleukomyeloneuropathy in an adult]. Rev Neurol (Paris) 1993 0.75
137 [Prognosis of cerebral ischemic accidents]. Rev Prat 1998 0.75
138 [Rehabilitation in aphasia]. Rev Infirm 1988 0.75
139 [Stiff-Man syndrome with late onset]. Rev Neurol (Paris) 1992 0.75
140 [Dementia: new concepts, new goals]. Rev Neurol (Paris) 2013 0.75
141 [Classification of parkinsonian syndromes via factorial discriminant analysis of brain SPECT data]. Rev Neurol (Paris) 2009 0.75
142 [Infarction of the red nucleus and crossed cerebellar diaschisis]. Rev Neurol (Paris) 1993 0.75
143 [Genetics of dominant autosomal forms of Alzheimer disease: 3 genes and one phenotype. Groupe de Recherche Francais sur la Maladie d'Alzheimer]. Rev Neurol (Paris) 1996 0.75
144 [Myositis disclosing systemic scleroderma]. Rev Neurol (Paris) 1984 0.75
145 [Steinert's disease and pregnancy. A case report and recent literature]. J Gynecol Obstet Biol Reprod (Paris) 1995 0.75
146 [Sequential treatment with H.M.G.-S and H.C.G. human gonadotropins of 18 cases of sterility with prolonged amenorrhea or anovulatory spaniomenorrhea]. Gynecol Obstet (Paris) 1968 0.75
147 [Huntington disease. Current state of research]. Presse Med 1994 0.75
148 Some clinical aspects of late onset parkinsonism. Clin Neurol Neurosurg 1992 0.75
149 [Henri Petit (1932-2014)]. Rev Neurol (Paris) 2015 0.75
150 [Multiple or multicentric cerebral glioma. Diagnostic and prognostic problems]. Presse Med 1985 0.75